Published 4 days ago • loading... • Updated 4 days ago

Heart drug developer Kardigan is targeting a $1.4 billion valuation in its U.S. IPO

Summary by Quartz

The Princeton, N.J., biotech plans to raise up to $373.3 million by selling 23.3 million shares priced between $14 and $16 each

The Princeton, N.J., biotech plans to raise up to $373.3 million by selling 23.3 million shares priced between $14 and $16 each

4 days ago·New York, United States

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated3 days agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Quartz broke the news in New York, United States 4 days ago on Thursday, June 11, 2026.

Sources are mostly out of (0)